In that single-arm study, the rate of primary adverse events within 7 days of ablation was 2.9%, with the most common ...

Dofetilide is under clinical development by Hyloris Pharmaceuticals and currently in Phase I for Atrial Flutter.

Looking back, Kokomo resident Mike Beatty knew he had something as a teenager, but he couldn’t put a name to it.

The new year has arrived, it’s a time for new beginnings, celebration, and reflection. However, the excitement of New Year’s festivities—and the overindulgence that often accompanies them—can lead to ...

Tempus AI TEM, an innovator in artificial intelligence-based healthcare solutions, has been attracting investors' interest since its successful IPO in June 2024. The company’s stock has demonstrated ...

No writing assistance was utilized in the production of this manuscript. Atrial fibrillation (AF) is the most common cardiac arrhythmia and predisposes patients to stroke and systemic embolism.

1 Department of Cardiology Research, Barts and The London NHS Trust, London, UK 2 Department of Cardiology, The Heart Hospital, London, UK Objective To investigate whether catheter ablation of atrial ...

Hein J. J. Wellens, M.D., F.A.C.C.; Sidney C. Smith, Jr., M.D., F.A.C.C. Atrial fibrillation (AF) is the most common arrhythmia seen in clinical practice, accounting ...

Adagio Medical Holdings, Inc. (NASDAQ: ADGM) recently disclosed in a Form 8-K filed with the Securities and Exchange Commission (SEC) that it has entered into a Limited Waiver and Amendment agreement ...